676 related articles for article (PubMed ID: 25850425)
1. Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.
Homma S; Thompson JL; Qian M; Ye S; Di Tullio MR; Lip GY; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Labovitz AJ; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2015 May; 8(3):504-9. PubMed ID: 25850425
[TBL] [Abstract][Full Text] [Related]
2. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.
Homma S; Thompson JL; Sanford AR; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Massie BM; Labovitz AJ; Di Tullio MR; Gabriel AP; Lip GY; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
Circ Heart Fail; 2013 Sep; 6(5):988-97. PubMed ID: 23881846
[TBL] [Abstract][Full Text] [Related]
3. Warfarin and aspirin in patients with heart failure and sinus rhythm.
Homma S; Thompson JL; Pullicino PM; Levin B; Freudenberger RS; Teerlink JR; Ammon SE; Graham S; Sacco RL; Mann DL; Mohr JP; Massie BM; Labovitz AJ; Anker SD; Lok DJ; Ponikowski P; Estol CJ; Lip GY; Di Tullio MR; Sanford AR; Mejia V; Gabriel AP; del Valle ML; Buchsbaum R;
N Engl J Med; 2012 May; 366(20):1859-69. PubMed ID: 22551105
[TBL] [Abstract][Full Text] [Related]
4. Left Ventricular Ejection Fraction and Risk of Stroke and Cardiac Events in Heart Failure: Data From the Warfarin Versus Aspirin in Reduced Ejection Fraction Trial.
Di Tullio MR; Qian M; Thompson JL; Labovitz AJ; Mann DL; Sacco RL; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Lip GY; Levin B; Mohr JP; Buchsbaum R; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Homma S;
Stroke; 2016 Aug; 47(8):2031-7. PubMed ID: 27354224
[TBL] [Abstract][Full Text] [Related]
5. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
[TBL] [Abstract][Full Text] [Related]
6. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
Ye S; Cheng B; Lip GY; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Qian M; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
Am J Cardiol; 2015 Sep; 116(6):904-12. PubMed ID: 26189039
[TBL] [Abstract][Full Text] [Related]
7. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
[TBL] [Abstract][Full Text] [Related]
8. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
[TBL] [Abstract][Full Text] [Related]
9. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.
Lee M; Saver JL; Hong KS; Wu HC; Ovbiagele B
Circ Heart Fail; 2013 Mar; 6(2):287-92. PubMed ID: 23264446
[TBL] [Abstract][Full Text] [Related]
10. Warfarin versus aspirin in patients with reduced cardiac ejection fraction (WARCEF): rationale, objectives, and design.
Pullicino P; Thompson JL; Barton B; Levin B; Graham S; Freudenberger RS;
J Card Fail; 2006 Feb; 12(1):39-46. PubMed ID: 16500579
[TBL] [Abstract][Full Text] [Related]
11. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials.
Kumar G; Goyal MK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1279-87. PubMed ID: 23182364
[TBL] [Abstract][Full Text] [Related]
12. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Does Not Increase Heart Failure Events in Heart Failure Patients: From the WARCEF Trial.
Teerlink JR; Qian M; Bello NA; Freudenberger RS; Levin B; Di Tullio MR; Graham S; Mann DL; Sacco RL; Mohr JP; Lip GYH; Labovitz AJ; Lee SC; Ponikowski P; Lok DJ; Anker SD; Thompson JLP; Homma S;
JACC Heart Fail; 2017 Aug; 5(8):603-610. PubMed ID: 28774396
[TBL] [Abstract][Full Text] [Related]
14. A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study.
Azoulay L; Dell'Aniello S; Simon TA; Langleben D; Renoux C; Suissa S
BMC Cardiovasc Disord; 2012 Jun; 12():49. PubMed ID: 22734842
[TBL] [Abstract][Full Text] [Related]
15. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
16. Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.
Chen ZM; Sandercock P; Pan HC; Counsell C; Collins R; Liu LS; Xie JX; Warlow C; Peto R
Stroke; 2000 Jun; 31(6):1240-9. PubMed ID: 10835439
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
18. CHA
Ye S; Qian M; Zhao B; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Lip GY; Thompson JL; Homma S;
Eur J Heart Fail; 2016 Oct; 18(10):1261-1266. PubMed ID: 27444219
[TBL] [Abstract][Full Text] [Related]
19. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
[TBL] [Abstract][Full Text] [Related]
20. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
